Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis Patients.

Okazaki, Masateru; Kobayashi, Hisanori; Ishii, Yutaka; Kanbori, Masayoshi; Yajima, Tsutomu

Okazaki, Masateru; Kobayashi, Hisanori; Ishii, Yutaka; Kanbori, Masayoshi; Yajima, Tsutomu.

Afiliação

Okazaki M; Immunology Department, Medical Affairs Division, Janssen Pharmaceutical K.K., Tokyo, Japan. mokazak1@its.jnj.com.
Kobayashi H; Immunology Department, Medical Affairs Division, Janssen Pharmaceutical K.K., Tokyo, Japan.
Ishii Y; Immunology Department, Medical Affairs Division, Janssen Pharmaceutical K.K., Tokyo, Japan.
Kanbori M; Japan Safety and Surveillance Division, Research and Development Division, Janssen Pharmaceutical K.K., Tokyo, Japan.
Yajima T; Biostatistics Department, Research and Development Division, Janssen Pharmaceutical K.K., Tokyo, Japan.

Rheumatol Ther ; 5(1): 185-201, 2018 Jun.

Article em En | MEDLINE | ID: mdl-29470832

Palavras-chave

Glucocorticoid; Golimumab; Methotrexate; Post-marketing surveillance; Rheumatoid arthritis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Rheumatol Ther Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google